The US Food and Drug Administration (FDA) is investigating potential risks linked to chimeric antigen receptor (CAR) T cell therapies, following reports of possible associations between such treatments and T cell malignancies in patients. The inquiry threatens to harm the image of an industry looking to expand the application of CAR-T cell therapies beyond cancer, and affects six products from major pharmaceutical companies. Industry players are collaborating with the FDA, with continuous patient monitoring playing a key role in ensuring overall safety.
Russian Hackers Attacking Government Entity Using Stealthy Living-Off-the-Land Tactics
Ukrainian government organizations continue facing relentless cyber threats from Russian-backed threat actors employing sophisticated evasion techniques to maintain persistent network access. Recent investigations have uncovered
.webp?w=0&resize=0,0&ssl=1 "Emerging Cyber Threats Featuring QR Codes ClickFix and LOLBins Challenging SOC Defenses")
